Following its discussions with government representatives and Indian pharmaceutical companies that are already actively addressing antimicrobial resistance (AMR), held in India in March, the Foundation will convene a high-level meeting on access to medicine and combatting AMR in Mumbai on Wednesday, 5 September, 2018. The goal is to share best practices and encourage mutual learning through an open discussion about improving access and pharmaceutical company action on AMR. This invitation-only event will be attended by representatives of companies analysed in the Foundation’s Access to Medicine Index, the Access to Vaccines Index and the Antimicrobial Resistance Benchmark.

The event will be opened with a keynote speech by Soumya Swaminathan, Deputy Director-General for Programmes at WHO, followed by a presentation and key insights from the Access to Medicine Foundation. The event will continue with a leadership panel discussion on access to medicine, moderated by Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation. Dilip Shah, Secretary General of the Indian Pharmaceutical Alliance, and Kanchana T.K., Director General of the Organization of Pharmaceutical Producers of India, will also speak on the role of pharmaceutical companies in improving access to medicine. The afternoon sessions include expert discussions about R&D, appropriate access to medicine and the responsible, sustainable manufacturing of antibiotics. Throughout the day, the speakers will exchange ideas in an open forum on how global pharmaceutical companies with a strong presence in India can expand good practice.



Related posts